Background. The Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R) is a 24-item questionnaire designed to assess risk of aberrant medication-related behaviors in chronic pain patients. The introduction of short forms of the SOAPP-R may save time and increase utilization by practitioners.
Methods. Subjects had previously been administered the full-length version of the SOAPP-R and been categorized as positive or negative for aberrant medication-related behaviors via the Aberrant Drug Behavior Index (ADBI). Short forms of the SOAPP-R were developed using lasso logistic regression. Sensitivity, specificity, and area under the curve (AUC) of all forms were calculated with respect to the ADBI using the complete data set, training-test analysis, and 10-fold cross-validation. The coefficient alpha of each form was also calculated. An external set of 12 pain practitioners reviewed the forms for content.
Introduction
Chronic pain is a condition that affects as many as 100 million Americans, with access to adequate care remaining an ongoing public health concern [1] [2] [3] [4] [5] . Opioids have been considered an option for the patient; these medications have advantages in certain situations [6, 7] , but they can lead to possible negative effects [8] [9] [10] [11] . Patients may exhibit drug-seeking behaviors, such as visiting multiple providers for prescriptions or misusing the medications by taking nonprescribed doses at more frequent intervals [11, 12] . When prescribing opioids, providers are now being asked to carefully consider the patient's risk, while the tools to assist the clinician in conducting a comprehensive risk assessment remain lacking [13] .
Validated questionnaires can assist in the screening of patients for possible future aberrant medication-related behaviors, with the original Screener and Opioid Assessment for Patients with Pain (SOAPP) [14] [15] [16] being among the most well known. As the SOAPP's items were conceptually derived [14] , a more empirically based questionnaire was needed, leading to the development of the 24-item Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R) [17] . The latter questionnaire has been validated [17] and cross-validated [18] .
One important practical concern shared by the SOAPP and the SOAPP-R, as well as by other questionnaires, is their length. Questionnaires with many items take time not only for the patients themselves but also add to the administrative burden incurred by providers. With increasingly limited funds and restricted provider time, there is a critical need for efficiency in the health care setting [19] . To save time and increase utilization by providers, researchers have studied different approaches to reducing test length. In the current context, a static short form has been introduced [20] , and a "proof of principle" has been established for a computerized variable-length version of the SOAPP-R that reduces its average number of items administered [21] . However, each of these approaches has a drawback. First, the existing static short form is based on the original SOAPP, not the more rigorously developed SOAPP-R. Only two of the short form's five items were selected for the SOAPP-R. Regarding the variable-length version of the SOAPP-R, this version requires that testing be conducted by computer, which limits its utility. Indeed, in some assessment settings, the infrastructure for computerized testing may not be present, in which case a short instrument that can be administered via paperand-pencil is more practical.
The primary aim of this research was to develop candidate SOAPP-R short forms and evaluate them statistically in comparison with the full-length SOAPP-R. A secondary aim was to obtain feedback on the content of the different forms from an external set of evaluators.
Comparisons between forms were made in order to recommend a single short form to be cross-validated in further study.
Methods
The Institutional Review Board at Tufts Medical Center and Tufts University Health Sciences Campus granted exempt status for this research project.
Subjects
The data set used in this retrospective study had previously been employed to develop a computerized variable-length version of the SOAPP-R [21] . The data set included item responses from 428 subjects who had completed the full-length version of the SOAPP-R, either as part of the SOAPP-R's original validation study (N ¼ 207) or its cross-validation study (N ¼ 221). Each patient in the original validation study was being treated at a pain clinic in Massachusetts, Ohio, or Pennsylvania. Each patient in the cross-validation study was being treated at a pain management center in Indiana, Massachusetts, New Hampshire, Pennsylvania, or Ohio. All patients had been prescribed opioids for chronic noncancer pain at their time of recruitment. Patients signed an informed consent form and were notified that study outcomes would not become part of their clinical record. Procedures of the studies were approved by participating centers' human subjects committees.
The SOAPP-R Table 1 shows the 24 self-report items comprising the SOAPP-R. Each of these items is scored on a five-point scale (0 ¼ "never," 1 ¼ "seldom," 2 ¼ "sometimes," 3 ¼ "often," 4 ¼ "very often"). A respondent's total score on the SOAPP-R is calculated by summing the scores of the individual items, after which the total score may be compared with a prespecified cut-off value. A positive result on the SOAPP-R (indicating greater risk) is obtained if the total score meets or exceeds the cut-off Table 1 Results of the item analysis (N ¼ 428); an "X" indicates that a given item is included in a given short form 
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value; a negative result (indicating lower risk) is obtained if the total score is less than the cut-off value. In its original validation study [17] , the SOAPP-R was found to exhibit adequate sensitivity (0.81) and specificity (0.68).
The Aberrant Drug Behavior Index
In addition to completing the full-length SOAPP-R, all 428 subjects in the study had completed Aberrant Drug Behavior Index (ADBI) assessments. The ADBI is a combination measure of multiple sources of information. The first such source is the Prescription Drug Use Questionnaire (PDUQ), a 20-minute interview that was derived from the American Society of Addiction Medicine's definition of addiction in patients with chronic pain [22] . The PDUQ consists of 42 items; a cut-off of 11 or greater was used previously [17, 18] and was likewise used herein. The second source of information included in the ADBI is the Prescription Opioid Therapy Questionnaire (POTQ), an 11-item instrument that is administered to the patient's physician [11] . A cut-off of 2 or greater was used based on previous work [17, 18] . Finally, the third element of the ADBI is a toxicology screen. Each patient's urine sample had been tested at a Quest Diagnostics lab for 1) illicit substances and 2) additional medications that had not been prescribed. A positive ADBI result was obtained if the result of the PDUQ was positive or if the result of the PDUQ was negative, but both the POTQ and toxicology screen were positive.
Short Form Development
One candidate short form was developed for each possible test length under 24 items. Selection of items was conducted using least absolute shrinkage and selection operator (lasso) logistic regression, with the result of the ADBI defined as the outcome to be predicted by the model. Lasso regression differs from standard multiple regression models in that it uses a penalty on the regression parameter values to force some of the predictors to have coefficients equal to zero [23] . Such predictors may be interpreted as having little ability to predict the outcome, given the other predictors. The larger the inputted value of the penalty, the more coefficients are required to take on a zero value. To produce a short form with a prespecified test length, the penalty was increased until the correct number of items was included in the form. Results were obtained using the glmnet package in R [24] .
Once the items comprising a given short form were determined, a cut-off value associated with the form was defined in order to separate positive individuals from negative individuals. A classic method to select the cutoff is to use the Youden J index, in which the cut-off is chosen so that the quantity sensitivity þ specificity -1 is maximized. However, because the Youden J index gives equal weight to sensitivity and specificity, it does not account for the possibility that one of the two statistics (sensitivity or specificity) might be more critical than the other. Within the context of predicting aberrant drug-related behavior in patients with chronic pain, previous literature has clearly indicated the relative importance of sensitivity [14, 17, 18] . To reflect this emphasis on sensitivity, the particular cut-off value selected for usage in the current study was the one maximizing the Youden J index, among only the subset of cut-off values satisfying sensitivity ! specificity.
Short Form Evaluation
For each short form, as well as the full-length SOAPP-R, the receiver operating characteristic (ROC) curve was constructed using the ADBI as the outcome of interest, and the area under the curve (AUC) statistic was computed. Sensitivity and specificity were also calculated based on the cut-off value that was chosen via the procedure described in the previous section. Results of the different short forms were compared with one another, as well as with the full-length SOAPP-R. In addition, the coefficient alpha statistic was calculated for each form; a coefficient alpha of 0.70 or greater is considered to indicate sufficient internal consistency according to a wellknown benchmark [25] . Each form's correlation with the short form of the Marlowe-Crowne Social Desirability Scale (MCSDS) was also computed to examine potential sensitivity to social desirability. A higher score on the MCSDS indicates a greater tendency to respond in a way that will be perceived as socially desirable. A lower score on a SOAPP-R form indicates lower risk (which would typically be perceived as socially desirable); hence, a correlation between a SOAPP-R form and the MCSDS that is closer to -1 suggests that the given SOAPP-R form is more sensitive to respondents' desire to appear socially desirable. On the other hand, a correlation between a SOAPP-R form and the MCSDS that is closer to zero suggests that the given SOAPP-R form is less sensitive to respondents' desire to appear socially desirable. Finally, the correlation between each short form and the full-length SOAPP-R was calculated using two methods: 1) the standard Pearson correlation between short form scores and full-length SOAPP-R scores and 2) the correlation obtained when applying Levy's [26] correction to account for the overlap of measurement errors between the short form and full-length form on common data. Bohlmeijer et al. [27] used a cut-off of 0.90 for the standard Pearson correlation and a cut-off of 0.80 for the corrected correlation as indicating substantial overlap between a short form and a fulllength form.
The initial analysis involved selecting the items and the cut-off value for each short form based on the complete data set, then evaluating the performance of the short forms based on the same data set. One disadvantage of such an analysis is that when both model training (here, the selection of items and cut-off values) and evaluation are conducted on the same data, spuriously strong performance by the short forms may be observed [23] . To address the possibility of such inflated performance, two additional analyses were conducted Finkelman et al.
to obtain AUC, sensitivity, specificity, and coefficient alpha values with model training separated from evaluation. First, a "training-test" analysis was undertaken in which model training was performed for each short form using only the data from the original validation data set, and then the resulting short forms were evaluated using only the data from the cross-validation data set. Second, a "10-fold cross-validation" was undertaken in which the complete data set was randomly divided into 10 parts ("folds") of as equal size as possible. Model training was performed using a combined data set of nine of the 10 folds, after which evaluation of the resulting short forms was done on the remaining fold. Ten replications of this procedure were conducted so that each fold would serve as the evaluation data set exactly once. Results of the 10 replications were then aggregated.
Forms were also scrutinized in terms of their content. In particular, the content of each form that exhibited potential based on statistical characteristics was subjected to evaluation by an external set of 12 pain practitioners from a pain care center in Massachusetts. The practitioners included at least one of each of the following: pain physicians, pain psychologists, pain nurse practitioners, registered nurses, clinical social workers specializing in pain, and chiropractors. Feedback about the content of the forms was solicited in an open-ended format; additionally, participants were asked which form (including the full-length SOAPP-R) they would be most likely to use with their own patients. The option "none of the above" was presented as a possible answer choice for the latter question.
Item Evaluation
Item distributions were calculated separately for ADBInegative individuals and ADBI-positive individuals. Each item's range of responses was examined based on these distributions. The AUC statistic was also computed for each item using the ADBI as the criterion to be predicted.
Results
Descriptive and demographic information was reported previously for this group of subjects [21] . The mean score on the full-length SOAPP-R was 20.4, with a standard deviation of 11.3. The ADBI was positive for 145 of the 428 subjects (34%). Four hundred twenty-six subjects had information on gender; among these, 243 were female (57%). Four hundred twenty-five subjects had information on age; among these, the mean age was 51.4 years, with a standard deviation of 13.0. Table 1 displays the results of the item analysis. The entire range of response options was used for all items except item 24 ("been treated for an alcohol or drug problem"). Regarding the ability of items to predict ADBI status, the items with the highest AUC values were item 9 ("taken more pain medication than you were supposed to," AUC ¼ 0.68), item 16 ("run out of pain medication early," AUC ¼ 0.67), item 5 ("tension in the home," AUC ¼ 0.67), and item 4 ("felt that things are just so overwhelming that you can't handle them," AUC ¼ 0.66). Table 2 presents results for the short forms and the fulllength form, based on the analysis in which both model training and evaluation were conducted using the complete data set. The second column of Table 2 identifies the set of items that comprise each short form using their item numbers; see the first column of Table 1 for a list of the items along with their numbers. Table 2 shows that the aforementioned four items with the highest AUC values (items 9, 16, 5, and 4) were the first four items selected for the short forms by the lasso procedure; the item with the second-highest AUC value (item 16) was actually selected prior to the item with the highest AUC value (item 9). Turning to specific short forms, all forms between items 7 and 12 (inclusive) had AUC values higher than that of the full-length SOAPP-R (0.76) while exhibiting coefficient alpha values near or above the benchmark of 0.70. The eight-item form exhibited low specificity relative to the other forms, leading to the exclusion of this form from further consideration. All short forms of 13 items or more were also excluded from further consideration at this stage, given that they had lower AUC values than the nine-item, 10-item, and 12-item forms while being longer.
Also shown in Table 2 are several correlations of interest. As displayed in the eighth column of the table, the Pearson correlation between the full-length SOAPP-R and the MCSDS was -0.47. Correlations between the short forms and the MCSDS ranged between -0.47 and -0.18, suggesting reasonable neutrality with respect to social desirability. Additionally, all short forms of seven items or more exhibited a Pearson correlation over 0.90 with the full-length SOAPP-R. These same forms exhibited a correlation of 0.80 or higher with the full-length SOAPP-R after applying Levy's correction.
Based on the above analysis of the complete data set, five short forms were given further consideration via the training-test analysis and 10-fold cross-validation. These were the seven-item form, nine-item form, 10-item form, 11-item form, and 12-item form (hereafter the SOAPP-R-7, SOAPP-R-9, SOAPP-R-10, SOAPP-R-11, and SOAPP-R-12, respectively). The five short forms listed above will be referred to as the "short forms of interest;" the items comprising these specific forms are indicated in Table 1 . Tables 3 and 4 display the results of the training-test analysis and the 10-fold cross-validation, respectively. In the training-test analysis, the results regarding predictive validity (AUC, sensitivity, and specificity) generally exhibited shrinkage, both for the short forms and the fulllength SOAPP-R. All short forms of interest had AUC values within 0.03 of that of the full-length SOAPP-R (0.74); the SOAPP-R-10 and SOAPP-R-12's values Table 2 Results of the short forms and full-length SOAPP-R: complete data set analysis (N Finkelman et al.
were within 0.01. All short forms of interest had coefficient alpha values at or above 0.70. In the 10-fold cross-validation, all short forms of interest, with the exception of the SOAPP-R-7, exhibited mean AUC values 0.01 lower than that of the full-length SOAPP-R (0.76). The mean coefficient alpha values of the SOAPP-R-7 and SOAPP-R-9 were below the benchmark of 0.70, whereas the SOAPP-R-10, SOAPP-R-11, and SOAPP-R-12's mean values were at or above this benchmark.
The evaluation of content by the external set of 12 pain practitioners included all five short forms of interest, as well as the full-length SOAPP-R. When asked which form they would be most likely to use with their own patients, one participant (8%) selected the SOAPP-R-11, nine participants (75%) selected the SOAPP-R-12, and two participants (17%) selected the full-length SOAPP-R (no participant selected the SOAPP-R-7, SOAPP-R-9, SOAPP-R-10, or "none of the above"). Among the nine participants who selected the SOAPP-R-12, seven directly referred to test length and/or respondent burden when explaining their choice. One additional participant who selected the SOAPP-R-12 did not directly allude to test length or respondent burden, but stated that the SOAPP-R-12 covers most of the basic concerns that he/she has in evaluating a patient for risk of aberrant behavior. The final participant who selected the SOAPP-R-12 did not explain his/her choice. The participant who selected the SOAPP-R-11 stated that this screener was the best combination of questions with minimal overlap. The two participants who selected the full-length SOAPP-R alluded to its being comprehensive/extensive when explaining their choice.
Discussion
When chronic opioid therapy is considered, formal risk stratification is increasingly becoming the standard of care. As multiple sources of data must be considered in assessing risk, time and clinician burden become critical factors in undertaking patient care. Each component of assessment should meet sufficient standards before considering its use within an evaluation protocol, particularly where the reliability and predictive validity of assessment instruments can be challenged in medico-legal settings [28] .
Each of the candidate short forms considered in this study underwent multiple modes of evaluation. The SOAPP-R-12 exhibited strong performance in both the statistical analysis and the evaluation by the external set of pain practitioners. This short form exhibited statistical characteristics comparable to those of previously developed computer-based versions of the SOAPP-R with similar average test lengths [21] . Moreover, compared with the full-length SOAPP-R, the SOAPP-R-12 reduces the number of items by 50%, a figure that has previously been identified in other fields as constituting a significant decrement in test length [29, 30] . Therefore, the results recommend the SOAPP-R-12 for the prediction of aberrant medication-related behaviors among chronic pain patients. Nevertheless, we emphasize that the current research represents only the first step in validating this form. Inferences from the current study are limited by its retrospective nature, particularly as the items comprising the SOAPP-R-12 (and other short forms) were administered as part of the full-length screener, rather than being administered as an intact set. As such, the results may be influenced by context effects and are not necessarily representative of the screening properties that would be obtained for an intact set. Future validation work should administer both the SOAPP-R-12 and the full-length form to the same participants, as the ultimate test of a screener is its performance when given prospectively in its operational format [31] . Testing should be performed in diverse settings, including both paper-based and computer-based administration when possible, in order to evaluate the generalizability of results. The cut-off value determined herein for the SOAPP-R-12 should also be validated, considering that sensitivities and specificities with respect to individual cut-off values demonstrated greater instability than the overall summary measure of discriminatory power, the AUC statistic. Hence, although the current study suggests the benefits of using the SOAPP-R-12, this form should not be considered fully validated unless the above steps are undertaken and the form's positive results are confirmed.
The validation cohort for the study included subjects who had previously been prescribed opioids for their pain. The study did not test whether the SOAPP-R forms are valid for predicting whether patients not on opioids would exhibit aberrant medication-related behaviors if opioids were prescribed to them. Therefore, the results cannot be generalized to opioid-naïve subjects. Nevertheless, the use of the obtained sample reflects real-world clinical practice in which a prescriber would want to consider the patient's risk for long-term opioid therapy.
Another important consideration that applies in a general screening context is that certain statistical properties of a screener are dependent on the prevalence of the outcome being predicted. In particular, an unduly low prevalence may contribute to a low positive predictive value, indicating that an unacceptably high percentage of positive findings are in fact false positives. Conversely, an unduly high prevalence may contribute to a low negative predictive value, indicating that an [32] . In the current study, 34% of subjects had a positive result on the ADBI, suggesting that the prevalence of aberrancy was neither unduly high nor unduly low in the given population. Nevertheless, as the prevalence of aberrancy differs from population to population, the effect of prevalence on the screening characteristics of the SOAPP-R-12 (as well as the fulllength SOAPP-R and other screeners) should be considered.
Finally, it should be emphasized that while the SOAPP-R was designed to include items that are subtle in terms of their scoring, and thus to be less prone to overt deception than the original SOAPP, the possibility of such deception is present in any screener regardless of length. Therefore, the SOAPP-R-12 should be considered as providing supplementary data that should be interpreted in the context of other information. Nevertheless, it may be useful in assisting providers with their assessments. Indeed, should the SOAPP-R-12 be validated in additional research, it may enhance the efficiency of screening and increase utilization.
Conclusions
The SOAPP-R-12 exhibits potential as a short screener to assess risk of aberrant medication-related behaviors among chronic pain patients. This form should be tested prospectively in future studies.
